Low-cost Wegovy-style pill sparks lawsuits and regulatory review, highlighting GLP-1 trial data, patent protection, and safety rules for obesity drugs.

Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast ...

Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...